个人简介
Professor Nanshan Zhong is a Medical Professor of Guangzhou Medical College, and a supervisor of respiratory medicine doctoral candidates. He graduated from Beijing Medical College, majoring in medical sciences. At present, he holds the posts of the Chairman of Guangzhou Association for Science & Technology, Director of Guangzhou Institute of Respiratory Diseases, First Affiliated Hospital of Guangzhou Medical College, and Director-general of China State Key Laboratory of Respiratory Diseases.
Professor Zhong is also a leader and principal investigator to more than 10 major scientific projects, including the State-973, State-863, Tenth State Five-year Plan, National Nature Science Grants, and WHO/GOLD global network. He has published a great number of papers in worldwide reputed SCI journals, including those in Nature Medicine, Lancet, BMJ, Am J Respir Crit Care Med, and more than 200 papers in State-level journals. His publications have received 438 citations. Besides, he has published 16 monographs including Respiratory Medicine (National College Textbooks for Medical Postgraduates), Medicine (National textbooks), Asthma: From Basic to Clinical, etc, and has gained 9 patents.
Over the past decades, Prof Zhong has been a leader scientist in promoting China’s respiratory medicine towards the forefront of international advances. He first developed and refined the definition of asymptomatic asthma, later cited by WHO, through his originally designed “simple bronchial provocation test" and epidemiological surveys. In a systemic review of etiology of chronic cough in China, he elucidated the
neuroinflammatory mechanisms to gastroesophageal reflux induced cough. His methods for diaphragmatic function assessment during exercise for the first time demonstrated protein-energy malnutrition in even 60% of patients with early to middle stage COPD, which generated a correction equation of basic energy intake in this cohort. A national epidemiological study steered by him showed the unprecedented prevalence of COPD in China. His famous research found that hydrosulfuryl-containing expectorants (carbocysteine) can be effective in preventing or reducing acute exacerbation of COPD. The results of this study were published in a Lancet paper (2008), which evoked huge international repercussions and was voted as “paper of the year 2008”. He has organized and participated in the development of a number of Chinese guidelines for diagnosis and management of bronchial asthma, COPD, chronic cough, SARS, and high-pathogenic avian flu. In 2009, he successfully established an MoE-administrated Changjiang Scholarship Team.
Due to his great achievements in medical practices and scientific education, Prof Zhong was also a recipient to Second and Third Prizes for National Natural Sciences, Outstanding Contribution Award, First Prize of Guangdong Science and Technology Awards, and Bethune Medal (2004). He became National May Day Labor Medalist (2003), National Moral Models (2007), European Respiratory Society Lifetime Honorary Fellow (2008), People Who Moved China 2009, Advanced Individual of National Medical Health Care System (2009), Fifth Higher School Teaching Masters Award (2009) and National Award for Achievements in Teaching (2009). He has been an Academician of Chinese Academy of Engineering since 1996, and was elected the President of Chinese Medical Association (2006-2011).
Education:
1955-1960 Bachelor of Medicine, (Beijing Medical University, Beijing, China)
1979-1980 Research Fellow (Respiratory Medicine, Royal Infirmary,
University of Edinburgh, Edinburgh, UK)
1980-1981 Research Fellow (Respiratory Medicine, St. Bartholomew's
Hospital, University of London, London, UK)
Honorary Degrees:
March 2007, Honarary Degree of Doctor of Medicine ,University of Edinburgh
Sept.2011, Doctor of Science, honoris causa, University of Birmingham
Professional Chronology:
1960-1971 Assistant lecturer, Faculty of Radiology, Beijing Medical
University
1971-1974 Intern, Department of Medicine, First Affiliated Hospital,
Guangzhou Medical University
1974-1978 Resident, Department of Medicine, Guangzhou Medical University
1981-present Director, Guangzhou Institute of Respiratory Disease
1978-1983 Attending Physician, Department of Medicine, Guangzhou Medical
University
1983-1986 Associate Professor, Department of Medicine, Guangzhou Medical
University
1986-1996 Professor, Department of Medicine, Guangzhou Medical University
1996-present Academician, Division of Health and Medicine, Chinese Academy
of Engineering
1986-1992 Dean, First Affiliate Hospital, Guangzhou Medical University
1992-2002 President, Guangzhou Medical University
2008-present Director, State Key Laboratory of Respiratory Disease in
Guangzhou
Professional Societies:
1982-1985 Member, Executive Committee, Chinese Medical Association
1985-1990 Member, WHO Advisory Panel on Smoking & Health
1989-2000 Member, Executive Committee, American College of Chest
Physician
1989-present Fellow, American College of Chest Physician (FCCP)
1995- Executive Director, Research & Education, Asian-Pacific Society
of Respirology
1994-2000 Vice-chairman, Chinese Society of Respiratory Diseases
1992- Vice-chairman, Guangdong Medical Association
1995-2010 Chairman, Guangzhou Association of Science and Technology
1993- Member, European Respiratory Society
1997- Executive member, Asian-Pacific Society of Respirology (APSR)
2000-2006 International Regent for PR China, American College of Chest
Physicians
2006-2011 President, Chinese Medical Association
2001-2007 Chairman, Chinese Society of Respiratory Diseases
2005-present Fellow, Royal College of Physicians of Ireland
2011-present Fellow of Royal College of Physician (FRCP Edinburgh )
2005-present Fellow, honoris causa, Hong Kong Academy of Medicine
2008-present Fellow, honoris causa, European Respiratory Society
University
1996- Editor in chief, Journal of Modern Chinese Medical Bioengineering
1995- Reviewer, J Respirology
1999- Reviewer, Respiratory Medicine
1992-2000 Co-editor in chief, Chinese Journal of Tuberculosis and Respiratory
Diseases
2000- Editor-in-chief, Chinese Journal of Tuberculosis and Respiratory
Disease
2004-present Editor-in-chief, CHEST (authorized Chinese Edition)
Main Contributions:
1) Defined "Asymptomatic asthma" (Latent asthma) which was quoted by the < Global
Initiative of Asthma> (WHO)1st edition ,1995 (Thorax 1990; 45: 860-5 , Chest 1992;
102: 1104-9 )
2) Chronic Obstructive Pulmonary Disease(COPD) : Prevalence in China (Am J
Respir Crit Care Med. 2007; 176(8):753-760)
Biomass is one of the most risk factors of COPD in women in the rural area in
China (Thorax. 2007; 62(10): 889-897
Thio compound was able to prevent acute exacerbation of COPD. Efficacy was
similar to inhaled corticosteroid plus long acting B2 agonnist (Lancet 2008; 371:
2013–18 Elected as "Paper of 2008" by the Lancet Editorial Board
Early intervention of COPD in the community may be benificial in reducing annual
FEV1 decline (BMJ. 2010 Dec 1;341:c6387.).
3) Diagnosis and management of Severe Acute Respiratory Syndrome(SARS)
Firstly described the real pathogen of SARS (Coronovirus but not Chlamydia ) in
the mainland of China (Lancet 2003; 362: 1353-58)
Right strategy in the management of SARS(Am J Respir Crit Care Med. 2003;
168(1): 7-9
Rational use of corticosteroid in the management of severe SARS (CHEST. 2006;
129: 1441-52, Brit Med J. 2006; 333: 289-91)
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus
in Rhesus macaque. Nat Med. 2005 Sept;11(9):944-51. ; Antiviral Therapy. 2004;
9:365-374
4) Etiology of chronic cough in China (Chest. 2013 Mar 1;143(3):613-20.)
5) Clinical characteristics of N7N9 infection (NEJM. 2013 May 22.)
近期论文
查看导师最新文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Books
NS Zhong, Diagnosis and Classification (asthma) in Global strategy for Asthma
Management and Prevention WHLBI/WHO workshop (GINA)(1995)(Chap5,
pp48-61)
NS Zhong, Management of Asthma in Developing Countries. In: Asthma. PJ Barnes.
Lippincott Raven Publishes Phildephia (1997), pp1869-1881.(Chapl27,
pp1869-1882)
NS Zhong et al. An English-Chinese-Japanese Illustrative Medical Dictionary. Man Lee
Bookstore Co Ltd. Hong Kong. 1985
NS Zhong et al. Updates in Modern Respiratory Disease. People’s Health Publishing
House. Beijing. 1994
NS Zhong et al. Designs in Medical Studies. Zhongshan University Publishing House.
Guangzhou. 2000
NS Zhong et al. A Precise Handbook for Diagnosis and Treatment of Respiratory
Diseases. Medimedia Co Ltd. 2001
NS Zhong et al. Prevention and Treatment Strategies to Atypical Infectious Pneumonia.
Guangdong Higher Education Publishing House. Guangzhou. 2003
NS Zhong et al. Diagnosis and Treatment of Atypical Infectious Pneumonia.
Guangdong Education Publishing House. 2003
NS Zhong (Chief Editor) Asthma: Basis & Clinical Practice
People's Health Publishing House 2004
NS Zhong (Co-Chief Editor) Internal Medicine (5th edition)People's Health Publishing
House 2006
NS Zhong (Chief Editor) Respiratory Medicine (For Postgraduate Student) 2006
NS Zhong (Chief Editor) Respiratory Medicine (2nd edition)
2011
Papers during the last ten years:
1) NS Zhong et al. Bronchial hyperresponsiveness in young students in China, relation
to respiratory symptoms, diagnosed asthma and risk factors. Thorax 1990; 45: 860-5
2) JP Zheng, NS Zhong. Energy metabolism in COPD. Chin Med J. 1991;71: 100-3.
3) NS Zhong, et al. Pressure support ventilation with facial (nasal) mask in the
management of patient with acute exacerbation of COPD. Chin J Tuber Respir Dis.
1992; 15:285-8.
4) NS Zhong et al. Is asymptomatic bronchial hyperresponsiveness an indication of
potential asthma? Chest 1992; 102: 1104-9
5) NS Zhong. Atopic diseases in the Chinese Community. Clin Exp Allergy 1994; 24;
297-298.
6) YM Luo, NS Zhong. Diaphramatic faitige in COPD. Chin J Tuber Respir Dis 1994;
17:suppl: s93-6.
7) YC Zhang, NS Zhong. Rehabilitalion -with facial (nasal) pressure support
ventilation in patient with stable stage of COPD. Chin J Tuber Respir Dis,
1994;17:suppl: s69-73.
8) YX Tan, NS Zhong. Energy and protein support in ventilated patients with acute
exacerbation of chronic Cor pulmonale . 1994; 33:527-530.
9) NS Zhong. Monitoning in mechanical ventilation. Chin J Tuber Respir Dis 1994; 17.
suppl: s26-31
10) Xu J, Zhong NS, et al. Impacts of EDRF and endothelin on the development of
pulmonary hypertension. J Beijing Med Univ. 1994; 26(suppl): 233-4
11) Xu J, Zhong NS, et al. Effects of hypoxia-induced endothelin release on the
proliferation of pulmonary artery smooth muscle cells. Chin J Tuber Respir Dis.
1994; 17(3): 185-9
12) Ran PX, Ouyang NT, Chen SC, Zhong NS. Expression of oncogene Jun in the lung
of rat with hypoxia. Chin J Histochem & Cytochem. 1995; 4(1): 14-8
13) YC Zhang, NS Zhong. COPD and noninvasive ventilation. RT Inernational . 1995;
4:99-106.
14) PX Ran, J Xu, NS Zhong. Effect of on endothelium- 1 and No synthase MRNA
expression in pulmonary artery and right heart of rat. Chi Med J 1995; 75:479-481.
15) J Xu, Ho s, Zhong NS et al. Endothelian-1 in the pathogenesis of chronic hypoxia
induced pulmonary hypertension. Chin J Tuber Respir Dis. 1995; 18:373-6.
16) YX Zeng, NS Zhong. Prediction of the level of continuous positive airway pressure
in the management of obstructive sleep apnea via nasal mask. Chin J Tuber Respir
Dis 1996; 19:269-72.
17) NS Zhong. New insights into risk factors of asthma. Respiratory 1996:1159-166
18) NS Zhong. Asthma management in Guangzhou. Respir 1996; 3:1-2
19) J Xu, NS Zhong. Interaction of TNF-A and ET-1 on the pathogenesis of animal
asthmatic model. Cli Exp Allergy 1997; 27:568-573.
20) J Xu. , Ren PX, NS Zhong. The effect of GM-CSF on endothelin-1 and endothelin
converting enzyme gene expression in human airway smooth muscle cells with or
without theoph lline incubation. Chin J Tuber Respir Dis, 1997 20(5): 276-9.
21) Ouyang NT, PX Ran, ZQ Du, T Zhu, NS Zhong. Expression of FGF-B and C-myc
in mouse lung tissue affected by hypoxia. Chin J Tuber Respir Dis, 1997;
20(l):22-24.
22) JP Zheng, NS Zhong et al. Prophylactic effects of beclomethasone inhalation on
bronchial hyperresponsivenese and asthma; a randomized, double blind parallel
controlled trial. Chin J Tuber Respir Dis. 1998; 21:9-12.
23) NT Ouyang, NS Zhong. Effects of dexamethasone on apoptosis of airway
inflammatory cells in asthmatic guinea pigs. Chin J Tuber Respir Dis, 1998 21(1l):
672-674.
24) WG He, J Xu, NS Zhong. Effect of inhaled-corticosteroid on the MRNA
expressions of endothelin-1 and endothelin converting enzyme in bronchial asthma.
Chin J Tuber Respir Dis, 1998; 21(6): 336-339.
25) HL Huang, BQ Sun, J Li, Mo HY, PX Ran, NS Zhong. Effects of low dose inhaled
corticosteriod plus low dose theophylline on levels of serum osteocalcin and ECP in
patients with asthma. Chin J Tuntern Med, 1998; 37(3):
26) H-iiang H, J Xu, NS Zhong. The changes of EGI and EG2 positive eosinophils and
their clinical significance in asthmatics. Chin J Tuber Respir Dis, 1998 21(10):
612-614.
27) YD Xu, SC Chen, NS Zhong. L-arginine prolonged the efficacy of inhaled NO on
the inhibition of hypoxia induced pulmonary hypertension. Chin J Tuber Respir Dis,
1998 21(4): 200-203.
28) JP Zheng, NS Zhong. Risk Factors of Environment and Occupation on lung diseases
in China. J. Enviro Med. 1999; 1(2): 359-382.
29) SC Wen, J Xu. , NS Zhong. Effect of antisense oligonucleotides on endothelin
converting enzyme expression and endothlin-1 release from airway smooth muscle
cells. Chin J Tuber Respir Dis, 1999; 22(5): 279-282.
30) J Xu, NS Zhong. Mechanisms of bronchial hyperresponsiveness:the interaction of
endothelin-1 and other cytokines. Respirology 1999; 4(4): 413-7.
31) JP Zheng, NS Zhong. Risk Factors of Environment and Occupation on lung diseases
in China. J. Enviro Med. 1999; 1(2): 359-382.
32) JH Liang, NS Zhong. A new type of liposomes delivery system. Chin J Tuber Respir
Dis, 1999; 22(8): 474.
33) SC Wen, YC Zhang, J Xu, NS Zhong. Endothelin-1 induces IL-8 expression in
human airway epithelia] cells by activating Nuclear factor-KB. Eur Respir J, 2000;
16(Supplement 31) 568s.
34) SC Wen, J Xu, NS Zhong. Effects of antisense endothelin converting enzyme
(ECE-1) RNA on TNFA induced ECE MRNA expression in bronchial epithelial
carcinoma cells. Eur Respir J. 2000; 16(Supplement 31) 178s.
35) He MZ, J Xu, H Zhang, AC Xue, NS Zhong. Quantitative assay of IL-8 MRNA
expression and IL-10 MRNA expression in peripheral blood mononuclear cells
(PBMCs). Eur Respir J. 2000; 16(Supplement 31) 283s.
36) YH Zhang, J Xu, NS Zhong. Activation of NF-KB. In respiratory syncytial virus
infected Balb/c mice. Eur Respir J. 2000; 16(Supplement 3 1) 283s.
37) W Zhang, NS Zhong, J Xu. Expression of GM-CSF MRNA in asthmatic patients.
Chin J Tuber Respir Dis, 2000; 23(9): 534-537
38) He MZ, Zhang H, NS Zhong. Quantification of IL-8 MRNA expression by
competitive RT-PCR in peripheral blood mononuclear cells in asthmatics. Journal of
Zhongshan University. 2000; 39(2): 92-96.
39) HL Huang, RX Chang, PX Ran, NS Zhong. Ifite-induced interleukin-5 and
interleukin-4 expressions in peripheral blood mononuclear cells from asthmatic
children with respiratory syncytial virus infection. Chin J Tuber Respir Dis, 2000;
22(4): 217-220.
40) AH Chen, NS Zhong. A cysteinyl leukotriene receptor antagonist (Zafirlukast)
inhibits leukotriene C4 induced endothelin-1 expression and release from human
airway epithelial cells and smooth muscle cells. Chin J Tuber Respir Dis, 2000;
23(10): 617-620.
41) J Li, HY Mo, NS Zhong. Effect of low dose of inhaled corticosteroid combined with
small dose of oral theophylline on the management of bronchial asthma. Chin J
Tuber Respir Dis, 2000 23(6): 336-339.
42) Asher I Boner A NS Zhong. Prevention of allergy and asthma: interim report.
Allergy 2000 Nov; 55(11): 1069-88
43) S Huang,NS Zhong. Chronic airway inflammation and atopic features in cough
variant asthma. Chemosphere, 2000 Jul; 41(1-2): 139-42.
44) GW Wong,Hui DS Chan HH Fok TF, Leung R, NS Zhong. Prevalence of
respiratory and atopic disorders in Chinese schoolchildren. Clin Exp Allergy, 2001;
31(8):1225-31.
45) NS Zhong. Pharmacokinetics and safety of oral theophylline. ATS 2001 –San
Francisco, California, USA 97th International Conference, 2001.
46) JP Zheng,NS Zhong. Normative values of pulmonary function testing in Chinese
adults. Chin Med J (Engl), 2002; 115(1): 50-4.
47) GW Wong, Li ST Hui DS Fok TF, NS Zhong. Individual allergens as risk factors for
asthma and bronchial hyperresponsiveness in Chinese children. Eur Respir J, 2002
Feb; 19(2): 288-93.
48) NS Zhong. Fighting SARS in grand collaboration: Our strategies. Chinese Medical
Journal. 2003;6(6):803~804
49) NS Zhong, et al. Fighting SARS in grand collaboration: our strategy. Chin J Tuber
Respir Dis. 2003;26(6):321~322;
50) NS Zhong. Diagnosis and treatment of SARS. Chin General Clin J. 2003; 19(10):
865-867
51) NS Zhong, GQ Zeng. Our strategies for fighting severe acute respiratory syndrome
(SARS). Am J Respir Crit Care Med. 2003; 168(1): 7-9
52) NS Zhong, et al. Epidemiology and cause of severe acute respiratory syndrome
(SARS) in Guangdong, People’s Republic of China, in February, 2003. Lancet 2003;
362: 1353-58
53) WK Lam, NS Zhong, WC TAN. Overview on SARS in Asia and the World.
Respirology. 2003; 8: S2-S5
54) K Tsang, NS Zhong. SARS: pharmacotherapy. Respirology 2003; 8:S25-S30
55) LYC Yam, RC Chen, NS Zhong. SARS: ventilatory and intensive care. Respirology
2003; 8: S31-S35
56) PM Calverley, W Boonsawat, Z Csek, NS Zhong, S Peterson, H. Olsson.
Maintenance therapy with budesonide and formoterol in chronic obstructive
pulmonary disease. Eur Respir J 2003; 22:912-919
57) BJ Zheng, Y Guan, J Li , NS Zhong. Prophylactic and therapeutic effects of small
interfering RNA targeting SARS-Coronavirus. Antiviral Therapy. 2004; 9:365-374
58) NS Zhong, JP Zheng, Michael JH, Du X. Comparison of Salmeterol/Fluticasone
Propionate via a SingleInhaler with Budesonide Alone in Control of
Mild-to-Moderate Asthma. Clinical Drug Investigation; 2004; 24(10):583-92
59) NS Zhong, G Wong. Epidemiology of Severe Acute Respiratory Syndrome (SARS):
Adults and Children. Paediatric Respiratory Review. 2004; 5(4)270-4
60) Li BJ, Tang Q, Cheng D, Qin C, Xie FY, Wei Q, Xu J, Liu Y, Zheng BJ, Woodle MC,
Zhong N, Lu PY. Using siRNA in prophylactic and therapeutic regimens against
SARS coronavirus in Rhesus macaque. Nat Med. 2005 Sept;11(9):944-51.
61) Mo H; Zeng G; Ren X; Li H; Ke C; Tan Y; Cai C; Lai K; Chen R; Chan Yeung M;
Zhong N. Longitudinal profile of antibodies against SARS-coronavirus in SARS
patients and their clinical significance. Respirology. 2006; 11(1):49-53
62) Chen RC, Tang XP, Tan SY, Liang BL, Wan ZY, Fang JQ, Zhong NS. Treatment of
SARS with glucosteroids: The Guangzhou experience. CHEST. 2006; 129: 1441-52
63) Zhong NS, Zeng GQ. What have we learned from SARS epidemics in China? Brit
Med J. 2006; 333: 289-91
64) Zheng JP, Yang L, Wu YM, Chen P, Wen ZG, Huang WJ, Shi Y, Wang CZ, Huang
SG, Sun TY, Wang GF, Xiong SD, Zhong NS. The efficacy and safety of
combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation
twice daily via accuhaler in Chinese patients with COPD. Chest.
2007;132(6):1756-63.
65) Liu S; Zhou Y; Wang X; Wang D; Lu J; Zheng J; Zhong N; Ran P. Biomass fuels are
the probable risk factor for chronic obstructive pulmonary disease in rural South
China. Thorax. 2007; 62(10): 889-897
66) Zhou BP, Zhong NS, Guan Yi. Treatment with convalescent plasma for influenza A
(H5N1) infection. NEJM. 2007; 357:14-15
67) Zhong N; Wang C; Yao W; Chen P; Kang J; Huang S; Chen B; Wang C; Ni D; Zhou
Y; Liu S; Wang X; Wang D; Lu J; Zheng J; Ran P. Prevalence of chronic obstructive
pulmonary disease in China: a large, population-based survey. Am J Respir Crit
Care Med. 2007; 176(8):753-760
68) Zhong NS, Zeng GQ. Pandemic planning in China: Applying lessons from severe
acute respiratory syndrome. Respirology. Respirology (2008) 13 (Suppl. 1),
S33–S35
69) Zheng JP, Kang J, Huang SG, Chen P, Yao WZ, Yang L, Bai CX, Wang CZ, Wang C,
Chen BY, Shi Y, Liu CT, Chen P*, Li Q, Wang ZS, Huang YJ, Luo ZY, Chen FP,
Yuan JZ, Yuan BT, Qian HP, Zhi RC, Zhong NS. Effect of carbocisteine on acute
exacerbation of chronic obstructive pulmonary disease (PEACE Study): a
randomised placebo-controlled study. Lancet 2008; 371: 2013–18
70) Zhong N. Preparing for the next flu pandemic: from SARS to avian flu. Singapore
Med J 2008; 49(8) : 595-598
71) He Z, Li B, Yu L, Liu Q, Zhong N, Ran P. Suppression of oxidant-induced
glutathione synthesis by erythromycin in human bronchial epithelial cells.
Respiration. 2008;75(2):202-9.
72) Li J, Zhou Z, An J, Zhang C, Sun B, Zhong N. Absence of relationships between
tuberculin responses and development of adult asthma with rhinitis and atopy. Chest.
2008 Jan;133(1):100-6.
73) Zhang D, Yin P, Freemantle N, Jordan R, Zhong N, Cheng KK. An assessment of
the quality of randomised controlled trials conducted in China. Trials. 2008 Apr
24;9:22.
74) Chen X, Sun R, Hu J, Mo Z, Yang Z, Liao D, Zhong N. Attenuation of
bleomycin-induced lung fibrosis by oxymatrine is associated with regulation of
fibroblast proliferation and collagen production in primary culture. Basic Clin
Pharmacol Toxicol. 2008 Sep;103(3):278-86.
75) Cai C, Zeng Y, Chen H, Gu Y, Zeng Q, Zhong N. Fibrobronchoscopic evidence of
endobronchial hairs in intrapulmonary teratoma with hemoptysis but without
trichoptysis. Am J Med Sci. 2008 Nov;336(5):441-4.
76) He C, Liu M, Zhou C, Zhang J, Ouyang M, Zhong N, Xu J. Detection of epidermal
growth factor receptor mutations in plasma by mutant-enriched PCR assay for
prediction of the response to gefitinib in patients with non-small-cell lung cancer. Int
J Cancer. 2009 Nov 15;125(10):2393-9.
77) Wu J, Xu J, Cai C, Gao X, Li L, Zhong N. Ag85B DNA vaccine suppresses airway
inflammation in a murine model of asthma. Respir Res. 2009 Jun 16;10:51.
78) Zhang Q, Lai K, Xie J, Chen G, Zhong N. Does unrestrained single-chamber
plethysmography provide a valid assessment of airway responsiveness in allergic
BALB/c mice?Respir Res. 2009 Jul 3;10:61.
79) He J, Ying W, Yang H, Xu X, Shao W, Guan Y, Jiang M, Wu Y, Zhong B, Wang D,
Tucker S, Zhong N. Gemcitabine plus cisplatin chemotherapy with concurrent
para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall
cell lung cancer larger than 3 cm in the greatest dimension. Anticancer Drugs. 2009
Oct;20(9):838-44.
80) Xie J, Zhang Q, Zhong N, Lai K. BAL fluid 8-isoprostane concentrations in
eosinophilic bronchitis and asthma. J Asthma. 2009 Sep;46(7):712-5.
81) Xie J, Zhang Q, Lai K, Zhong N. Measurement of nasal airway resistance and
response in mice. Int Arch Allergy Immunol. 2010;151(3):262-4.
82) Lu W, Ran P, Zhang D, Peng G, Li B, Zhong N, Wang J. Sildenafil inhibits
chronically hypoxic upregulation of canonical transient receptor potential expression
in rat pulmonary arterial smooth muscle. Am J Physiol Cell Physiol. 2010
Jan;298(1):C114-23.
83) Chen L, Lai K, Xie J, Zhong N. Establishment of airway eosinophilic bronchitis
mouse model without hyperresponsiveness by ovalbumin. Clin Exp Med. 2011
Mar;11(1):19-24.
84) Peng G, Lu W, Li X, Chen Y, Zhong N, Ran P, Wang J. Expression of store-operated
Ca2+ entry and transient receptor potential canonical and vanilloid-related proteins
in rat distal pulmonary venous smooth muscle. Am J Physiol Lung Cell Mol Physiol.
2010 Nov;299(5):L621-30.
85) Lu W, Ran P, Zhang D, Lai N, Zhong N, Wang J. Bone morphogenetic protein 4
enhances canonical transient receptor potential expression, store-operated Ca2+
entry, and basal [Ca2+]i in rat distal pulmonary arterial smooth muscle cells. Am J
Physiol Cell Physiol. 2010 Dec;299(6):C1370-8.
86) Zhou Y, Hu G, Wang D, Wang S, Wang Y, Liu Z, Hu J, Shi Z, Peng G, Liu S, Lu J,
Zheng J, Wang J, Zhong N, Ran P. Community based integrated intervention for
prevention and management of chronic obstructive pulmonary disease (COPD) in
Guangdong, China: cluster randomised controlled trial. BMJ. 2010 Dec
1;341:c6387.
87) Guan Y, Zeng Q, Yang H, Zheng J, Li S, Gao Y, Deng Y, Mei J, He J, Zhong N.
Pulmonary alveolar proteinosis: quantitative CT and pulmonary functional
correlations. Eur J Radiol. 2012 Sep;81(9):2430-5.
88) Li J, Huang Y, Lin X, Zhao D, Tan G, Wu J, Zhao C, Zhao J, Spangfort MD, Zhong
N; China Alliance of Research on Respiratory Allergic Disease (CARRAD).
Influence of degree of specific allergic sensitivity on severity of rhinitis and asthma
in Chinese allergic patients. Respir Res. 2011 Jul 15;12:95.
89) Chung KF, Zhang J, Zhong N. Outdoor air pollution and respiratory health in Asia.
Respirology. 2011 Oct;16(7):1023-6.
90) Chen L, He Z, Qin L, Li Q, Shi X, Zhao S, Chen L, Zhong N, Chen X. Antitumor
effect of malaria parasite infection in a murine Lewis lung cancer model through
induction of innate and adaptive immunity. PLoS One. 2011;6(9):e24407.
91) Zhong N, Zheng J, Wen F, Yang L, Chen P, Xiu Q, Yao W, Sun T, Zhao Z, Shen H,
Shi Y, Lin J, Li Q. Efficacy and safety of budesonide/formoterol via a dry powder
inhaler in Chinese patients with chronic obstructive pulmonary disease. Curr Med
Res Opin. 2012 Feb;28(2):257-65.
92) Yang Z, Wang Y, Zhong S, Zhao S, Zeng X, Mo Z, Qin S, Guan W, Li C, Zhong N.
In vitro inhibition of influenza virus infection by a crude extract from Isatis
indigotica root resulting in the prevention of viral attachment. Mol Med Rep. 2012
Mar;5(3):793-9.
93) Zeng G, Zhong N. Translational medicine: what is in a name from the perspective of
Chinese clinicians?Sci China Life Sci. 2011 Dec;54(12):1077-80.
94) Li H, Qiu Y, Zhang X, Xu X, Liao D, Wang W, Wen D, Dong Q, Xian H, Wang D,
Zhong N, He J. Establishment of a lung cancer biobank of a southern chinese
population. J Thorac Dis. 2009 Dec;1(1):17-22.
95) McEvoy RD, Anderson CS, Antic NA, Chen B, He Q, Heeley E, Huang S, Huang Y,
Wang J, Zhong N. The sleep apnea cardiovascular endpoints (SAVE) trial: Rationale
and start-up phase. J Thorac Dis. 2010 Sep;2(3):138-43.
96) Li J, Huang Y, Lin X, Zhao D, Tan G, Wu J, Zhao C, Zhao J, Spangfort MD, Lai X,
Zhong N; China Alliance of Research on Respiratory Allergic Disease (CARRAD).
Factors associated with allergen sensitizations in patients with asthma and/or rhinitis
in China. Am J Rhinol Allergy. 2012 Mar-Apr;26(2):85-91.
97) Zhang Q, Illing R, Hui CK, Downey K, Carr D, Stearn M, Alshafi K, Menzies-Gow
A, Zhong N, Fan Chung K. Bacteria in sputum of stable severe asthma and
increased airway wall thickness. Respir Res. 2012 Apr 18;13:35.
98) Zhong N. Nipping it in the bud: An inspiring mission for prevention and
management of COPD. J Thorac Dis. 2012 Apr 1;4(2):102-5.
99) Lai K, Luo W, Zeng G, Zhong N. Diagnosis and treatment of chronic cough in China:
an insight into the status quo. Cough. 2012 Jul 28;8(1):4.
100) Zeng G, Sun B, Zhong N. Non-smoking-related chronic obstructive pulmonary
disease: a neglected entity?Respirology. 2012 Aug;17(6):908-12.
101) Lai X, Li J, Xiao X, Liu E, Zhang C, Wang H, Gjesing B, Zhong N, Spangfort MD.
Specific IgG4 production during house dust mite immunotherapy among age,
gender and allergic disease populations. Int Arch Allergy Immunol.
2013;160(1):37-46.
102) Wang H, Yang L, Zou L, Huang D, Guo Y, Pan M, Tan Y, Zhong H, Ji W, Ran P,
Zhong N, Lu J. Association between chronic obstructive pulmonary disease and
lung cancer: a case-control study in Southern Chinese and a meta-analysis. PLoS
One. 2012;7(9):e46144.
103) Guan W, Zheng J, Gao Y, Jiang C, Xie Y, An J, Yu X, Liu W, Zhong N.
Leukotriene D4 and methacholine bronchial provocation tests for identifying
leukotriene-responsiveness subtypes. J Allergy Clin Immunol. 2013
Feb;131(2):332-8. e1-4.
104) Yang L, Qiu F, Lu X, Huang D, Ma G, Guo Y, Hu M, Zhou Y, Pan M, Tan Y,
Zhong H, Ji W, Wei Q, Ran P, Zhong N, Zhou Y, Lu J. Functional polymorphisms of
CHRNA3 predict risks of chronic obstructive pulmonary disease and lung cancer in
Chinese. PLoS One. 2012;7(10):e46071.
105) Wang J, Jiang Q, Wan L, Yang K, Zhang Y, Chen Y, Wang E, Lai N, Zhao L, Jiang
H, Sun Y, Zhong N, Ran P, Lu W. Sodium tanshinone IIA sulfonate inhibits
canonical transient receptor potential expression in pulmonary arterial smooth
muscle from pulmonary hypertensive rats. Am J Respir Cell Mol Biol. 2013
Jan;48(1):125-34.
106) Cui J, Zhou Y, Tian J, Wang X, Zheng J, Zhong N, Ran P. A discriminant function
model as an alternative method to spirometry for COPD screening in primary care
settings in China. J Thorac Dis. 2012 Dec;4(6):594-600.
107) Liu C, Chen R, Luo W, Lai K, Zhong N. Neurogenic airway inflammation induced
by repeated intra-esophageal instillation of HCl in guinea pigs : Neurogenic Airway
Inflammation Induced by Repeated Intra-esophageal Instillation of HCl in Guinea
Pigs. Inflammation. 2013 Apr;36(2):493-500.
108) Deng F, Tang Q, Zheng Y, Zeng G, Zhong N. Infrared thermal imaging as a novel
evaluation method for deep vein thrombosis in lower limbs. Med Phys. 2012
Dec;39(12):7224-31.
109) Lai K, Chen R, Lin J, Huang K, Shen H, Kong L, Zhou X, Luo Z, Yang L, Wen F,
Zhong N. A prospective, multicenter survey on causes of chronic cough in china.
Chest. 2013 Mar 1;143(3):613-20.
110) Huang D, Yang L, Liu Y, Zhou Y, Guo Y, Pan M, Wang Y, Tan Y, Zhong H, Hu M,
Lu W, Ji W, Wang J, Ran P, Zhong N, Zhou Y, Lu J. Functional polymorphisms in
NFκB1/IκBα predict risks of chronic obstructive pulmonary disease and lung cancer
in Chinese. Hum Genet. 2013 Apr;132(4):451-60.
111) Zhang C, Li J, Lai X, Zheng Y, Gjesing B, Spangfort MD, Zhong N. House dust
mite and storage mite IgE reactivity in allergic patients from Guangzhou, China.
Asian Pac J Allergy Immunol. 2012 Dec;30(4):294-300.
112) Yang Z, Wang Y, Zheng Z, Zhao S, Zhao J, Lin Q, Li C, Zhu Q, Zhong N.
Antiviral activity of Isatis indigotica root-derived clemastanin B against human and
avian influenza A and B viruses in vitro. Int J Mol Med. 2013 Apr;31(4):867-73.
113) Hai-Nv Gao, Hong-Zhou Lu, Bin Cao, Bin Du, Hong Shang, Jian-He Gan,
Shui-Hua Lu, Yi-Da Yang, Qiang Fang, Yin-Zhong Shen, Xiu-Ming Xi, Qin Gu,
Xian-Mei Zhou, Hong-Ping Qu, Zheng Yan, Fang-Ming Li, Wei Zhao, Zhan-Cheng
Gao, Guang-Fa Wang, Ling-Xiang Ruan, Wei-Hong Wang, Jun Ye, Hui-Fang Cao,
Xing-Wang Li, Wen-Hong Zhang, Xu-Chen Fang, Jian He, Wei-Feng Liang, Juan
Xie, Mei Zeng, Xian-Zheng Wu, Jun Li, Qi Xia, Zhao-Chen Jin, Qi Chen, Chao
Tang, Zhi-Yong Zhang, Bao-Min Hou, Zhi-Xian Feng, Ji-Fang Sheng, Nan-Shan
Zhong, Lan-Juan Li. Clinical Findings in 111 Cases of Influenza A (H7N9) Virus
Infection. NEJM. 2013 May 22.